3 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
04/2016
-
02/2010 |
3 | Peptides (Polypeptides)IBA
01/2014
-
02/2010 |
2 | Proteins (Proteins, Gene)FDA Link
01/2018
-
11/2001 |
2 | ErbB Receptors (EGF Receptor)IBA
04/2016
-
12/2004 |
2 | Somatostatin Receptors (Somatostatin Receptor)IBA
01/2014
-
02/2010 |
2 | Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2014
-
02/2010 |
2 | gallium 68-DOTA-lanreotideIBA
02/2010
-
02/2010 |
2 | Insulin (Novolin)FDA Link
08/2003
-
12/2001 |
2 | Keratins (Keratin)IBA
11/2001
-
01/2000 |
1 | RadiopharmaceuticalsIBA
01/2022 |
1 | WD repeat containing planar cell polarity effectorIBA
01/2018 |
1 | MMEIBA
01/2018 |
1 | beta CateninIBA
01/2018 |
1 | AcidsIBA
04/2016 |
1 | gallium 68 PSMA-11IBA
04/2016 |
1 | 23-seleno-25-homotaurocholic acidIBA
04/2016 |
1 | Dictyostelium severin protein (severin)IBA
04/2016 |
1 | lipoarabinomannan (LAM)IBA
04/2016 |
1 | N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA
04/2016 |
1 | melanin-concentrating hormone receptorIBA
04/2016 |
1 | multidrug resistance-associated protein 1IBA
04/2016 |
1 | fluorocholineIBA
04/2016 |
1 | fluoromethylcholineIBA
04/2016 |
1 | 5-(2-fluoroethyl) 2,4- diethyl- 3- (ethylsulfanylcarbonyl)- 6- phenylpyridine- 5- carboxylateIBA
04/2016 |
1 | radium Ra 223 dichlorideIBA
04/2016 |
1 | Erlotinib Hydrochloride (CP 358,774)FDA Link
04/2016 |
1 | Yttrium-90IBA
04/2016 |
1 | AerosolsIBA
04/2016 |
1 | Choline (Choline Chloride)IBA
04/2016 |
1 | Ciprofloxacin (Cipro)FDA LinkGeneric
04/2016 |
1 | Dihydroxyphenylalanine (Dopa)IBA
04/2016 |
1 | Liposomes (Liposome)IBA
04/2016 |
1 | Methionine (L-Methionine)FDA Link
04/2016 |
1 | SolutionsIBA
04/2016 |
1 | Verapamil (Calan)FDA LinkGeneric
04/2016 |
1 | Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
04/2016 |
1 | Member 1 Subfamily B ATP Binding Cassette TransporterIBA
04/2016 |
1 | somatostatin receptor 2IBA
01/2014 |
1 | EnzymesIBA
08/2012 |
1 | Radioisotopes (Radionuclides)IBA
02/2010 |
1 | Tumor Biomarkers (Tumor Markers)IBA
02/2010 |
1 | yttrium(III)- 1,4,7,10- tetraazacyclotetradecane- N,N',N'',N'''- tetraacetic acidIBA
02/2010 |
1 | serum P-component (CIt)IBA
02/2010 |
1 | fluorodopa F 18IBA
02/2010 |
1 | ThrombinFDA Link
06/2007 |
1 | EDDA (NiEDDA)IBA
09/2005 |
1 | 3-Tyr-octreotideIBA
09/2005 |
1 | OsteoprotegerinIBA
04/2005 |
1 | Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA
04/2005 |
1 | Monoclonal AntibodiesIBA
12/2004 |
1 | prolinedithiocarbamate (PDTC)IBA
12/2004 |
1 | Glucose (Dextrose)FDA LinkGeneric
08/2003 |
1 | Insulin Glargine (Lantus)FDA Link
08/2003 |
1 | PoisonsIBA
08/2001 |
1 | Chlorpropham (CIPC)IBA
08/2001 |
1 | CarbamatesIBA
08/2001 |